Condition: Human Immunodeficiency Virus (HIV) · HIV Pre-Exposure Prophylaxis · Sponsor: Merck Sharp & Dohme LLC
Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HIV-1 infection as well as or better than a standard (usual) pre-exposure prophylaxis (PrEP) taken once a day * About the safety of MK-8527 and if people tolerate it
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006) | Birmingham, Alabama, United States | Recruiting |
| USA Health University Hospitals ( Site 0020) | Mobile, Alabama, United States | Recruiting |
| UCLA Center for Clinical AIDS Research and Education ( Site 0004) | Los Angeles, California, United States | Recruiting |
| Bridge HIV - San Francisco Department of Public Health ( Site 0001) | San Francisco, California, United States | Recruiting |
| Whitman-Walker Institute ( Site 0016) | Washington D.C., District of Columbia, United States | Recruiting |
| University of Miami RAPID Research ( Site 0003) | Miami, Florida, United States | Recruiting |
| Orlando Immunology Center ( Site 0021) | Orlando, Florida, United States | Recruiting |
| Hope Clinic of the Emory Vaccine Center ( Site 0009) | Decatur, Georgia, United States | Recruiting |
| University of Illinois Chicago ( Site 0027) | Chicago, Illinois, United States | Recruiting |
| University Medical Center New Orleans ( Site 0024) | New Orleans, Louisiana, United States | Recruiting |
| Open Arms Healthcare Center ( Site 0025) | Jackson, Mississippi, United States | Recruiting |
| Rutgers New Jersey Medical School ( Site 0010) | Newark, New Jersey, United States | Recruiting |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07044297